Initial biologic events that underlie sexual transmission of HIV are poorly understood. LC, which are dendritic cells (DC) found within mucosal epithelial surfaces, are potent antigen presenting cells and are the most likely initial targets for HIV following sexual exposure to virus. My scientific work has attempted to uncover the types of cellular and molecular interactions that occur between HIV and LC/DC. My early work in this area helped to delineate two major pathways by which HIV interacts with LC: an infection pathway and a """"""""capture"""""""" pathway. Infection of LC is mediated through CD4 and HIV co-receptors (CCR5 and CXCR4), whereas capture of virions occurs via the C-type lectin DC-SIGN. Interestingly, we were first to describe a novel ex vivo tissue model of primary HIV infection using skin explants. In single LC that spontaneously emigrated from explants, we could detect and quantify HIV infection by flow cytometry. Using this model, we then showed that pre-treatment of skin explants with chemically modified analogues of RANTES (potential microbicides that prevent binding of HIV to CCR5) blocked HIV infection of LC and subsequent T cell infection in a dose-dependent manner. Also using this explant model, we have recently shown that certain CCR5 genotypic patterns regulate levels of HIV infected within LC. Currently, we are 1) examining how different HIV clades infect and affect LC and 2) defining the type and nature of the T cells that preferentially interact with HIV-infected LC. Taken together, this work has helped in understanding (and potentially blocking) the early biologic events that occur following sexual exposure to HIV. In regard to the antigen presenting cell function of HIV-infected LC/DC, I initially studied the immunologic function of LC taken from the skin of HIV-infected individuals. Recently, we have determined that HIV-infected DC secrete HIV gp120, even in the presence of potent anti-retroviral drugs, and that this protein induces marked dysfunction in co-cultured T cells. Interestingly, addition of soluble CD4 to co-cultures completely restores T cell function. These results may have important implications for HIV-infected individuals who have continued immunosuppression despite effective anti-retroviral therapy. 100% AIDS-RELATED

Agency
National Institute of Health (NIH)
Institute
Division of Clinical Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC010094-06
Application #
6758268
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Grivel, J C; Penn, M L; Eckstein, D A et al. (2000) Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J Virol 74:5347-51
Grivel, J C; Malkevitch, N; Margolis, L (2000) Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in ex vivo-infected human lymphoid tissue. J Virol 74:8077-84
Blauvelt, A; Glushakova, S; Margolis, L B (2000) HIV-infected human Langerhans cells transmit infection to human lymphoid tissue ex vivo. AIDS 14:647-51
Kawamura, T; Cohen, S S; Borris, D L et al. (2000) Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med 192:1491-500
Asada, H; Klaus-Kovtun, V; Golding, H et al. (1999) Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures. J Virol 73:4019-28
Chougnet, C; Cohen, S S; Kawamura, T et al. (1999) Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J Immunol 163:1666-73
Papadopoulos, E J; Sassetti, C; Saeki, H et al. (1999) Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol 29:2551-9
Anderson, H A; Bergstralh, D T; Kawamura, T et al. (1999) Phosphorylation of the invariant chain by protein kinase C regulates MHC class II trafficking to antigen-processing compartments. J Immunol 163:5435-43